Observational studyClinical and experimental nephrology2025
Impact of vaccination on the development of acute kidney injury in Japanese COVID-19 patients: a retrospective observational analysis.
Observational study in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19-associated AKI has received attention for some time because of its association with mortality, but has not been investigated in Japan. Diabetes mellitus, male sex, aging, etc., have been reported as risk factors for the development of AKI, and recently, it has been reported that unvaccinated status is a risk factor. AKI is thought to be related to inflammation and microthrombi caused by cytokine storms and lung‒kidney connections. The COVID-19 vaccine has the potential to prevent AKI because it lowers cytokine levels and prevents severe disease.
methodsA retrospective cohort study collected clinical and laboratory data from patients admitted to the Tokyo Metropolitan Institute for Geriatrics and Gerontology with a COVID-19 diagnosis between February 2020 and September 2022.
resultsAmong the 929 patients, 113 (12.2%) had AKI, 33 (3.6%) died, and the mortality rate of patients with AKI was 19.5%, which was significantly higher than that of patients without AKI (1.3%) (p < 0.001). Diabetes mellitus, unvaccinated status, and heart disease were associated with AKI complications (p = 0.001, 0.008, and 0.011, respectively).
conclusionsCOVID-19-associated AKI significantly increased mortality in Japanese hospitalized patients. Unvaccinated status emerged as an independent risk factor for AKI, in addition to traditional risk factors such as diabetes mellitus and heart disease. These findings suggest a potential protective role of vaccination against COVID-19-associated AKI.
Indexed as
Identifiers
40736658What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.